Nabriva Therapeutics plc - Ordinary Shares (NBRV): Price and Financial Metrics
NBRV Price/Volume Stats
| Current price | $1.42 | 52-week high | $8.45 |
| Prev. close | $1.42 | 52-week low | $1.22 |
| Day low | $1.35 | Volume | 717,200 |
| Day high | $1.90 | Avg. volume | 29,344 |
| 50-day MA | $1.55 | Dividend yield | N/A |
| 200-day MA | $1.78 | Market Cap | 45.46M |
NBRV Stock Price Chart Interactive Chart >
Nabriva Therapeutics plc - Ordinary Shares (NBRV) Company Bio
Nabriva is a clinical-stage biopharmaceutical company engaged in the research and development of novel antibiotics to treat serious infections, with a focus on the pleuromutilin class of antibiotics. The company was founded in 2006 and is based in Wien, Austria.
NBRV Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | -93.32% |
| 5-year | -99.73% |
| YTD | N/A |
| 2023 | 0.00% |
| 2022 | -87.38% |
| 2021 | -75.25% |
| 2020 | -81.67% |
| 2019 | -9.59% |
Continue Researching NBRV
Want to do more research on Nabriva Therapeutics plc's stock and its price? Try the links below:Nabriva Therapeutics plc (NBRV) Stock Price | Nasdaq
Nabriva Therapeutics plc (NBRV) Stock Quote, History and News - Yahoo Finance
Nabriva Therapeutics plc (NBRV) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...